Åsa Riisberg new Chair of Atlas Antibodies’ Board

2022-12-09 08:00

Åsa Riisberg, professional board member and former partner of EQT AB, has been appointed new Chair of the Board of Patricia Industries’ wholly owned subsidiary Atlas Antibodies.

Atlas Antibodies is a leading fast-growing provider of innovative and high-quality antibodies and recombinant antibody expressions to researchers around the world. Åsa Riisberg will succeed Torben Jørgensen, who leaves the Board, effective January 1, 2023.

Åsa Riisberg is currently board member of Patricia Industries, Bonnier News, Dagens Nyheter, Internetmedicin, Netcompany and Bonnier Group. She is also a Strategic Advisory Board member at Chiesi Group and MFIN at Stockholm School of Economics.

“I would like to thank Torben Jørgensen for his great contribution to the Board, as both member and Chair, during the past 16 years. With his industrial experience and life science expertise, Torben has been instrumental in the building of the joint group, including the recent acquisitions of evitria and HistoCyte Laboratories. I am very glad that Åsa Riisberg has accepted the position as new Chair. Åsa brings extensive experience from investment management, M&A, and the life science industry. We look forward to working together with her, making Atlas Antibodies a leading global life science tools company” says Christian Cederholm, Head of Patricia Industries, a part of Investor AB.

As of January 1, 2023 Atlas Antibodies’ Board includes Åsa Riisberg, Mathias Uhlén, Lotta Ljungqvist and Louise Kores.

Torben Jørgensen will remain as an advisor to Patricia Industries and member of Advanced Instruments' Board. 

Read more about Atlas Antibodies here 

We create value for people and society by building strong and sustainable businesses

Proposed Dividend

Read more here

Year-End Report 2022

More information here

Investor B

206.30

-1.86 %

Shareholders